Warberg Asset Management LLC Raises Holdings in Stereotaxis Inc. $STXS

Warberg Asset Management LLC raised its stake in Stereotaxis Inc. (NYSEAMERICAN:STXS) by 260.1% in the second quarter, HoldingsChannel.com reports. The fund owned 1,201,500 shares of the company’s stock after purchasing an additional 867,878 shares during the quarter. Warberg Asset Management LLC’s holdings in Stereotaxis were worth $2,547,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Geode Capital Management LLC lifted its position in Stereotaxis by 0.9% during the second quarter. Geode Capital Management LLC now owns 1,478,201 shares of the company’s stock worth $3,135,000 after buying an additional 13,891 shares during the period. Prescott Group Capital Management L.L.C. lifted its stake in shares of Stereotaxis by 44.5% during the second quarter. Prescott Group Capital Management L.L.C. now owns 1,139,252 shares of the company’s stock worth $2,415,000 after purchasing an additional 350,600 shares in the last quarter. Independent Advisor Alliance lifted its position in Stereotaxis by 3.2% during the 1st quarter. Independent Advisor Alliance now owns 191,695 shares of the company’s stock worth $337,000 after acquiring an additional 5,900 shares in the last quarter. Nuveen LLC purchased a new position in shares of Stereotaxis in the first quarter valued at $130,000. Finally, Deutsche Bank AG acquired a new stake in shares of Stereotaxis during the first quarter valued at about $82,000. 45.35% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Stereotaxis

In related news, Director Paul J. Isaac purchased 20,000 shares of the firm’s stock in a transaction that occurred on Friday, November 14th. The stock was acquired at an average price of $2.24 per share, for a total transaction of $44,800.00. Following the transaction, the director directly owned 2,786,557 shares of the company’s stock, valued at $6,241,887.68. This trade represents a 0.72% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. 17.77% of the stock is owned by company insiders.

Stereotaxis Stock Up 3.6%

Shares of STXS stock opened at $2.32 on Friday. Stereotaxis Inc. has a fifty-two week low of $1.54 and a fifty-two week high of $3.59. The stock has a market capitalization of $211.28 million, a P/E ratio of -8.00 and a beta of 1.65. The stock has a 50-day simple moving average of $2.87 and a 200 day simple moving average of $2.54.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on the stock. Roth Capital reaffirmed a “buy” rating and issued a $4.00 price target on shares of Stereotaxis in a report on Wednesday, November 12th. UBS Group set a $4.00 target price on Stereotaxis in a research note on Wednesday, November 5th. One research analyst has rated the stock with a Buy rating, According to MarketBeat, the company has a consensus rating of “Buy” and an average target price of $4.00.

Stereotaxis Company Profile

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.